Thoroughness in implementing projects immediately after licensing, with the backup of local authorities and industrial park developers, has contributed to the country’s record disbursement of foreign ...

Pham Duc Toan, consulting manager at Vietnam Investment Consulting, spoke with VIR’s Kim Oanh about the current situation involving these markets. What is your assessment about the investment ...

Aubrey Plaza has deleted her Instagram account one week after the death of her late husband, Jeff Baena. While Plaza’s account was previously active, a message now ...

Sri Lankans are still hoping for a better future. But in Colombo, its hotels are already prepped for success. And the cuisine is as delicious as ever I was in Colombo when Dr Manmohan Singh ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) today and set a price target of $110.00. Discover outperforming stocks and invest ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program, despite their primary focus on hepatitis management. The company's market cap has surged past $1 billion ...

Following the publication of encouraging results from Phase 2 studies for two investigational cancer treatments, Vir Biotechnology (VIR, Financials) saw a notable 58% increase in its stock price ...

Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational pipeline candidates, VIR-5818 and VIR-5500, for the treatment of various ...

Shares of Vir Biotechnology (NASDAQ:VIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data for two antitumor agents developed using its PRO-XTEN masking ...

VIR-5818 showed 50% tumor shrinkage in HER2-positive cancers and 33% partial responses in heavily pretreated CRC patients. VIR-5500 achieved PSA reductions in 100% of prostate cancer patients ...